Skip to main navigation menu Skip to main content Skip to site footer

Search for patients with pulmonary hypertension at the Hospital Universitario San Ignacio

Búsqueda de pacientes con hipertensión pulmonar en el Hospital Universitario San Ignacio




Section
Research article

How to Cite
Search for patients with pulmonary hypertension at the Hospital Universitario San Ignacio.
rev. colomb. neumol. [Internet]. 2013 Sep. 30 [cited 2024 Nov. 24];25(3). Disponible en: https://doi.org/10.30789/rcneumologia.v25.n3.2013.106

Dimensions
PlumX
license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Darío Londoño, MD., MSc.
    Claudio Villaquirán MD., MSc.
      Elena Mora Figueroa, MD.

        Darío Londoño, MD., MSc.,

        Internista, Neumólogo, Unidad de Neumología. Departamento de Medicina Interna. Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.


        Claudio Villaquirán MD., MSc.,

        Internista, Neumólogo, Unidad de Neumología. Departamento de Medicina Interna. Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.


        Elena Mora Figueroa, MD.,

        Internista, Departamento de Medicina Interna, Hospital Universitario San Ignacio. Bogotá, Colombia.


        Objective: to describe the prevalence of pulmonary hypertension, as assessed by echocardiography, in patients with or without indication for active search of pulmonary hypertension, at San Ignacio University Hospital, over the period from January 2004 to June 2012.

        Materials and methods: descriptive, cross-cut study, in which the clinical histories of patients with or without indication for active search of pulmonary hypertension were reviewed, taking into account a background of systemic sclerosis and cirrhosis of the liver, candidates for liver transplant, in the first group, and patients with end-stage kidney disease and cirrhosis of the liver and portal hypertension who were not candidates for liver transplant, in the second group.

        Results: 331 clinical records were reviewed, 39,5% of which had an echocardiogram at some moment of the study period. in the group of patients with indication for active search, a 25%-prevalence of pulmonary hypertension was found in patients with systemic sclerosis, and a 27,9%-prevalence was found in patients with cirrhosis and indication for liver transplant. in the group of patients without indication for active search, the prevalence of pulmonary hypertension was 51% in patients with end-stage kidney disease, and 35,71% in patients with cirrhosis and portal hypertension without indication for liver transplant.

        Conclusions: in our community, the prevalence of pulmonary hypertension as determined by echocardiography is higher than that reported globally. However, echocardiography is not performed as a screening test in an important percentage of patients.


        Article visits 802 | PDF visits 114


        Downloads

        Download data is not yet available.
        1. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023-30. Epub 2006 Feb 2.
        2. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al; ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119:2250-94.
        3. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Hervé P, Rainisio M, Simonneau G. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol. 2002;40:780-8.
        4. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, Kahan A, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum. 2005;52:3792-800.
        5. Benjaminov FS1, Prentice M, Sniderman KW, Siu S, Liu P, Wong F. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut. 2003;52:1355-62.
        6. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:S1-153.
        7. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003;62:1088-93.
        8. Kuo PC, Plotkin JS, Gaine S, Schroeder RA, Rustgi VK, Rubin LJ,
        9. et al. Portopulmonary hypertension and the liver transplant candidate. Transplantation. 1999;67:1087-93.
        10. V illaquirán C, Dueñas R, Londoño D. Guías para el diagnóstico y tratamiento de la hipertensión arterial pulmonar. Rev Colomb Neumol. 2010; 22 S1:1-127.
        Sistema OJS 3.4.0.7 - Metabiblioteca |